Brief: Heat Biologics Says On Track To Complete Enrollment Of Phase 2 Lung Cancer Trial In Q2 2019

Scorpius Holdings

28/03/2019 11:44

March 28 (Reuters) - Heat Biologics Inc  HTBX.O :
    * HEAT BIOLOGICS - COMPANY REMAINS ON TRACK TO COMPLETE
ENROLLMENT
OF PHASE 2 LUNG CANCER TRIAL IN Q2 2019 AND REPORT ADDITIONAL
INTERIM DATA IN Q4 2019
    * HEAT BIOLOGICS INC - FULLY FUNDED THROUGH COMPLETION OF
HS-110
PHASE 2 TRIAL WITH APPROXIMATELY $28 MILLION OF CASH AND
INVESTMENTS AT YEAR END
    * HEAT BIOLOGICS INC - ADDITIONAL $6.9 MILLION IN GRANT
FUNDS
EXPECTED IN Q2 2019

Source text: [http://bit.ly/2FG6j86]
Further company coverage:  HTBX.O 

 (Reuters.Briefs@thomsonreuters.com)